XIV Fórum Nacional de Políticas de Saúde no Brasil – Doenças Raras News XIV Fórum Nacional de Políticas de Saúde no Brasil – Doenças Raras By Zalika Famaceutica|2024-12-02T09:24:28-03:00September 26, 2023|News|
Protegendo Nossos Jovens: Prevenção de Doenças Raras na Comunidade Judaica News Protegendo Nossos Jovens: Prevenção de Doenças Raras na Comunidade Judaica By Zalika Famaceutica|2024-12-02T09:24:29-03:00September 14, 2023|News|
Nuvaxovid COVID-19 Vaccine Receives Full Authorization in Europe News Nuvaxovid COVID-19 Vaccine Receives Full Authorization in Europe By Zalika Famaceutica|2024-12-02T09:24:29-03:00July 7, 2023|News|
8th Edition – 10 years –The scenario of Rare Diseases in Brazil 2023 News 8th Edition – 10 years –The scenario of Rare Diseases in Brazil 2023 By Zalika Famaceutica|2024-12-02T09:24:30-03:00June 19, 2023|News|
Novo remédio mais caro do mundo: para que serve e por que custa tão caro o Hemgenix By Zalika Famaceutica|2024-12-02T09:24:32-03:00December 21, 2022|News|
SUS fornecerá Zolgensma, um dos remédios mais caros do mundo, para crianças com AME By Zalika Famaceutica|2024-12-02T09:24:33-03:00December 3, 2022|News|
WORLD HEALTH ORGANIZATION UPDATES EMERGENCY USE LISTING FOR NOVAVAX NUVAXOVID COVID-19 VACCINE AS A PRIMARY SERIES IN ADOLESCENTS AND AS A BOOSTER IN ADULTS By Zalika Famaceutica|2024-12-02T09:24:34-03:00November 29, 2022|News|
FDA APPROVES TREMELIMUMAB PLUS DURVALUMAB FOR ADULT PATIENTS WITH UNRESECTABLE HCC News FDA APPROVES TREMELIMUMAB PLUS DURVALUMAB FOR ADULT PATIENTS WITH UNRESECTABLE HCC By Zalika Famaceutica|2024-12-02T09:24:35-03:00October 25, 2022|News|
EXECUTIVES FROM ZALIKA FAMARCÊUTICA DURING A MEETING WITH THE EXECUTIVE SECRETARY OF THE MINISTRY OF HEALTH, BRUNO DALCOLMO IN BRASÍLIA News EXECUTIVES FROM ZALIKA FAMARCÊUTICA DURING A MEETING WITH THE EXECUTIVE SECRETARY OF THE MINISTRY OF HEALTH, BRUNO DALCOLMO IN BRASÍLIA By Zalika Famaceutica|2022-10-25T18:14:53-03:00September 23, 2022|News|